BCMA antibodies and use of same to treat cancer and immunological disorders
US11078291B2 · kind B2 · utility
1Cited by
22References
66Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2019 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | May 14, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides humanized antibodies that specifically bind to BCMA. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting BCMA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.